Medical term:

Avicidin

An investigational radioimmunotherapeutic agent for treating advanced therapeutically refractive cancers of the colon, ovarian and prostate, which delivers high-dose RT to metastatic tumours, while minimising exposure of normal tissues, especially bone marrow. Avicidin was discontinued in phase-II trials due to a high incidence of unacceptable diarrhea, which was atributed to cross-reactivity of the Avicidin anti-Epcam antibody with the intestine.

Latest Searches:
Yocon - yield - Yesavage - Yersiniosis - Yersinieae - Yersinia - Yerkes - Yergason - yerba - Yeo - yellows - yellow - Yellofins - Yello - Yellen - yawning - yaws - yaw - Yatapoxvirus - Yasmin -
- Service manuals - MBI Corp